Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ocuguard LX
- Development stage
- Unknown
- Lead developer
- Orchidia Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Ocuguard LX is an oral dietary supplement developed by Orchidia Pharmaceutical, specifically formulated to support ocular health and manage the progression of age-related macular degeneration (AMD). Its composition is based on the AREDS2 (Age-Related Eye Disease Study 2) clinical trial formula, containing a combination of the macular carotenoids lutein and zeaxanthin, alongside antioxidant vitamins (C and E) and essential minerals (zinc and copper). These ingredients function by accumulating in the macula to filter harmful high-energy blue light and by neutralizing reactive oxygen species (ROS) that contribute to oxidative stress and retinal cell damage. While listed under Orchidia's ophthalmic and food supplement portfolios, it is primarily utilized as a nutraceutical intervention for patients at risk of advanced AMD.
- Brand names
- Ocuguard LX
- Other names
- Ocuguard LX Tablets
Beyond the preview
Go deeper on Ocuguard LX.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ocuguard LX.